top of page
Browse by category
Search
Tirzepatide reduced the risk of developing T2Dm by 94% in adults with pre-diabetes and obesity or overweight
Eli Lilly and Company has announced positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating...
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines
The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...
Scottish Medicines Consortium accepts tirzepatide (Mounjaro) for obesity in eligible adults
The Scottish Medicines Consortium (SMC) has accepted Eli Lilly and Company’s tirzepatide (Mounjaro) for restricted use within NHS...
Tirzepatide was superior to placebo for MASH resolution
Results from Eli Lilly and Company’s SYNERGY-NASH that evaluated the investigational use of tirzepatide in adults with biopsy-proven...
Tirzepatide effective even for those with diabetes and other complications
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide,...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment
Two studies presented at this year's European Congress on Obesity in Venice, Italy, have reported that tirzepatide consistently reduces...
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity
Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Tirzepatide may help lower blood pressure in adults with obesity
Tirzepatide significantly lowered the systolic blood for nearly 500 adults with obesity who took the medication for about eight months,...
Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide
Novo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...
Journal Watch 18/10/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Browse by tag
bottom of page